We are live on
!
Find out more
WF
Welch & Forbes Portfolio holdings
AUM
$8.23B
1-Year Est. Return
17.62%
This Fund
S&P 500
This Quarter
Est. Return
+11.73%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$5.58B
AUM Growth
+$459M
(+9%)
Cap. Flow
-$69.3M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
29.39%
Holding
389
New
19
Increased
84
Reduced
179
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$17.4M |
| 2 |
Lincoln Electric
LECO
|
+$9.55M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$7.33M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.54M |
| 5 |
Haleon
HLN
|
+$4.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stanley Black & Decker
SWK
|
+$12.2M |
| 2 |
Meta Platforms (Facebook)
META
|
+$8.4M |
| 3 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$7M |
| 4 |
Ball Corp
BALL
|
+$6.38M |
| 5 |
First Trust Senior Loan Fund ETF
FTSL
|
+$5.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.37% |
| 2 | Technology | 20.21% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.04% |
| 5 | Consumer Staples | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ligand Pharmaceuticals
LGND
$5.94B
| – | – |
-5,049
| Closed | -$271K |
|
377
Lincoln National
LNC
$8.8B
| – | – |
-6,000
| Closed | -$263K |
|
378
iShares MBS ETF
MBB
$39.1B
| – | – |
-2,479
| Closed | -$228K |
|
379
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.69B
| – | – |
-191,610
| Closed | -$2.24M |
|
380
ScottsMiracle-Gro
SMG
$3.97B
| – | – |
-5,650
| Closed | -$241K |
|
381
Sempra
SRE
$58.6B
| – | – |
-3,596
| Closed | -$269K |
|
382
iShares ESG MSCI USA Leaders ETF
SUSL
$1.13B
| – | – |
-4,876
| Closed | -$301K |
|
383
Uber
UBER
$143B
| – | – |
-28,160
| Closed | -$746K |
|
384
Vontier
VNT
$4.49B
| – | – |
-22,578
| Closed | -$377K |
|
385
Vodafone
VOD
$37.2B
| – | – |
-12,502
| Closed | -$142K |
|
386
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
| – | – |
-4,808
| Closed | -$232K |
|
387
Vanguard Ultra-Short Bond ETF
VUSB
$8.94B
| – | – |
-72,808
| Closed | -$3.56M |
|
388
Dentsply Sirona
XRAY
$2.75B
| – | – |
-7,206
| Closed | -$204K |
|
|
TWTR
389
DELISTED
Twitter, Inc.
TWTR
| – | – |
-5,500
| Closed | -$241K |
|
Similar funds
OC
LGF
CCM
CL
WJWM
WA
GGHC
CCM
Welch & Forbes's Q4 2022 Portfolio in Review
As of Q4 2022, Welch & Forbes held 389 positions worth $5.58B, up 9% from $5.12B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Welch & Forbes's Q4 2022 filing shows 19 new, 84 increased, 179 reduced and 21 closed positions. Its largest new stake was GSK: 521,101 shares worth $18.3M. The largest sale was Stanley Black & Decker, an estimated $12.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
- Welch & Forbes's largest Q4 2022 buy was GSK: 521,101 shares worth $18.3M.
- Welch & Forbes added most to Lincoln Electric in Q4 2022, an estimated $9.55M increase.
- Welch & Forbes's biggest Q4 2022 reduction was Stanley Black & Decker, cutting an estimated $12.2M.
- Welch & Forbes fully exited WisdomTree Japan Hedged Equity Fund in Q4 2022, selling an estimated $7M.
- Welch & Forbes's ten largest holdings make up 29% of its $5.58B portfolio in Q4 2022.
- Welch & Forbes opened 19 new positions and closed 21 in Q4 2022.
- Welch & Forbes's portfolio value rose 9% quarter-over-quarter to $5.58B.
Based on Welch & Forbes's 13F filing for Q4 2022, filed 2 Feb 2023.